Perrigo appointment
This article was originally published in The Tan Sheet
Executive Summary
Judy Brown, Senior VP and Corporate Controller for Perrigo, will assume her new role as the company's CFO and Chief Accounting Officer July 1, the Allegan, Mich.-based firm announces March 2. Brown will replace current CFO Douglas Schrank, who has been at Perrigo for six years. Brown is a certified public accountant who previously worked for Whirlpool and Ernst & Young. In her current role, Brown has helped lead the company through its acquisition of Agis Industries, which was completed in March (1"The Tan Sheet" Nov. 22, 2004, p. 6)...
You may also be interested in...
Perrigo Moves In On Major Generic Firms With Agis Acquisition
Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.